Overview

Full Product Details

Author:   Richard K. Burt
Publisher:   Taylor & Francis Ltd
Imprint:   CRC Press
Dimensions:   Width: 21.00cm , Height: 28.50cm , Length: 28.00cm
Weight:   1.700kg
ISBN:  

9781587060311

ISBN 10:   1587060310
Pages:   512
Publication Date:   10 May 2004
Audience:   College/higher education ,  General/trade ,  Tertiary & Higher Education ,  General
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print  
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

1. When is a Stem Cell Really a Stem Cell?, 2. Embryonic Stem Cells: Unique Potential to Treat Autoimmune Diseases, 3. Neural Stem Cells and Oligodendrocyte Progenitors in the Central Nervous System, 4. Turning Blood into Liver, 5. Adipose Tissue-Derived Adult Stem Cells: Potential for Cell Therapy, 6. Hematopoietic Stem Cell Biology: Relevance to Autoimmunity, 7. Properties and Therapeutic Potentials of Adult Stem Cells from Bone Marrow Stroma (MSCs), 8. Regeneration of Cardiomyocytes from Bone Marrow Stem Cells and Application to Cell Transplantation Therapy, 9. Clinical Trials of Hematopoietic Stem Cells for Cardiac and Peripheral Vascular Diseases, 10. The Stem Cell Continuum: A Plastic Plasticity, 11. Adult Stem Cell Plasticity, 12. Collection and Expansion of Stem Cells, 13. The Extracellular Matrix as a Substrate for Stem Cell Growth and Development and Tissue Repair, 14. Gene Transfer into Human Hematopoietic Stem Cells: Problems and Perspectives, 15. The Etiopathogenesis of Autoimmunity, 16. Overview of Immune Tolerance Strategies, 17. Death Receptor-Mediated Apoptosis and Lymphocyte Homeostasis, 18. Shifting Paradigms in Peripheral Tolerance, 19. Dendritic Cells Control the Balance between Tolerance and Autoimmunity, 20. CD4+ T Regulatory Cells and Modulation of Undesired Immune Responses, 21. Major Histocompatibility Complex and Autoimmune Disease, 22. Analyzing Complex Polygenic Traits: The Role of Non-HLA Genes in the Susceptibility to Autoimmune Disorders, 23. Drug-Induced Autoimmunity, 24. Evidence for a Role of Infections in the Activation of Autoreactive T Cells and the Pathogenesis of Autoimmunity, 25. Molecular Analysis of Immunity, 26. Immune Reconstitution after Hematopoietic Stem Cell Transplantation, 27. Historical Perspective and Rationale of HSCT for Autoimmune Diseases, 28. High-Dose Immune Suppression without Hematopoietic Stem Cells for Autoimmune Diseases, 29. Autologous Stem Cell Transplantation in Animal Models of Autoimmune Diseases, 30. Allogeneic Hemopoietic Stem Cell Transplantation in Animal Models of Autoimmune Disease, 31. Mobilization and Conditioning Regimens in Stem Cell Transplant for Autoimmune Diseases, 32. Infection in the Hematopoeitic Stem Cell Transplant Recipient with Autoimmune Disease, 33. Immunological Aspects of Multiple Sclerosis with Emphasis on the Potential Use of Autologous Hemopoietic Stem Cell Transplantation, 34. Axonal Injury and Disease Progression in Multiple Sclerosis, 35. Monitoring Disease Activity in Multiple Sclerosis, 36. Intense Immunosuppression Followed by Autologous Stem Cell Transplantation in Severe Multiple Sclerosis Cases: MRI and Clinical Data, 37. Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Finding Equipoise, 38. Molecular and Cellular Pathogenesis of Systemic Lupus Erythematosus, 39. Definition, Classification, Activity and Damage Indices in Systemic Lupus Erythematosus, 40. Lupus Nephritis, 41. Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus, 42. Treatment of Rheumatoid Arthritis, 43. Haemopoietic Stem Cell Transplantation for Rheumatoid Arthritis—World Experience and Future Trials, 44. Autologous Stem Cell Transplantation for Refractory Juvenile Idiopathic Arthritis (JIA), 45. Immunology of Scleroderma, 46. Hematopoietic Stem Cell Transplantation for Systemic Sclerosis, 47. High-Dose Immunosuppressive Chemotherapy with Autologous Stem Cell Support for Chronic Autoimmune Thrombocytopenia, 48. High-Dose Chemotherapy with Haematopoietic Stem Cell Transplantation in Primary Systemic Vasculitis, Behçet’s Disease, 49. Hematopoietic Stem Cell Transplantation in the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy, 50. Hematopoietic Stem Cell Therapy for Patients with Refractory Myasthenia Gravis, 51. Hematopoietic Stem Cell Transplantation in Patients with Autoimmune Bullous Skin Disorders, 52. Idiopathic Inflammatory Myositis, 53. Hematopoietic Stem Cell Transplantation as Treatment for Type 1 Diabetes, 54. Autologous Hematopoietic Stem Cell Transplantation for Crohn’s Disease, 55. Bronchial Asthma and Idiopathic Pulmonary Fibrosis as Potential Targets for Hematopoietic Stem Cell Transplantation, 56. Autologous Stem Cell Transplantation in Relapsing Polychondritis, 57. Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Diseases, Index

Reviews

Author Information

Richard K. Burt Chief, Division of Immunotherapy Department of Medicine Feinberg School of Medicine Northwestern University Chicago, Illinois, U.S.A Alberto M. Marmont Professor Emeritus Division of Hematology and Stem Cell Transplantation San Martino’s Hospital Genoa, Italy

Tab Content 6

Author Website:  

Countries Available

All regions